Evidence map›Paper›PMID 34770949›Full record

ReviewMolecules (Basel, Switzerland)2021

Unravelling the Anticancer Mechanisms of Traditional Herbal Medicines with Metabolomics.

Omolola R Oyenihi, Ayodeji B Oyenihi, Joseph O Erhabor, Motlalepula G Matsabisa, Oluwafemi O Oguntibeju

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Plant Metabolomics: The Future of Anticancer Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Omolola R OyenihiOxidative Stress Research Centre, Phytomedicine and Phytochemistry Group, Department of Biomedical Sciences, Cape Peninsula University of Technology, P.O. Box 1906, Bellville 7535, South Africa.
Ayodeji B OyenihiFunctional Foods Research Unit, Faculty of Applied Sciences, Cape Peninsula University of Technology, P.O. Box 1906, Bellville 7535, South Africa.ORCID 0000-0001-9912-1539
Joseph O ErhaborDepartment of Pharmacology, University of the Free State, P.O. Box 339, Bloemfontein 9300, South Africa.ORCID 0000-0003-2958-9827
Motlalepula G MatsabisaDepartment of Pharmacology, University of the Free State, P.O. Box 339, Bloemfontein 9300, South Africa.ORCID 0000-0003-2921-8882
Oluwafemi O OguntibejuOxidative Stress Research Centre, Phytomedicine and Phytochemistry Group, Department of Biomedical Sciences, Cape Peninsula University of Technology, P.O. Box 1906, Bellville 7535, South Africa.ORCID 0000-0002-7299-1128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolite profiling of cancer cells presents many opportunities for anticancer drug discovery. The Chinese, Indian, and African flora, in particular, offers a diverse source of anticancer therapeutics as documented in traditional folklores. In-depth scientific information relating to mechanisms of action, quality control, and safety profile will promote their extensive usage in cancer therapy. Metabolomics may be a more holistic strategy to gain valuable insights into the anticancer mechanisms of action of plants but this has remained largely unexplored. This review, therefore, presents the available metabolomics studies on the anticancer effects of herbal medicines commonly used in Africa and Asia. In addition, we present some scientifically understudied 'candidate plants' for cancer metabolomics studies and highlight the relevance of metabolomics in addressing other challenges facing the drug development of anticancer herbs. Finally, we discussed the challenges of using metabolomics to uncover the underlying mechanisms of potential anticancer herbs and the progress made in this regard.

Indexed as

MetabolomicsAntineoplastic Agents, PhytogenicDrug DevelopmentDrugs, Chinese HerbalHumansNeoplasmsAntineoplastic Agents, PhytogenicDrugs, Chinese Herbalcancerherbmetabolic reprogrammingmetabolomicsphytomedicine

Identifiers

PMID34770949
PMCPMC8587539

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.